Economic Outlook Report 2021 | Special Edition
Economic Outlook Report 2021 Special edition Clients and Industries, February 2021
1 Economic Outlook Report 2021 | Special Edition
COVID-19 Update 4 Global economy 6 Thailand economy 10
2 Economic Outlook Report 2021 | Special Edition
COVID-19 update
3 Economic Outlook Report 2021 | Special Edition
Coronavirus vaccine progress
Coronavirus Vaccine Tracker Leading vaccines
PHASE 1 PHASE 2 PHASE 3 AUTHORI ED APPROVED ABANDONED 2020 2021 May June July Aug Sept Oct Nov Dec Jan Feb Mar April o Pfizer/BioNTech Trial 2 20 44k 2 -70°c 95% start Approvals Pfizer was the first company to report positive phase 3 clinical data. Vaccines Vaccines in Vaccines in Vaccines in Vaccines Vaccines It plans produce 50M doses in 2020 Results testing safety expanded large-scale early or limited approved for abandoned and 1.3B in 2021. and dosage safety trials efficacy tests use full use after trials Moderna Trial 30k 2 2-8°c 95% start Approvals Top Three Coronavirus Vaccine Compare Modern and Pfizer both use a new vaccine approach involving Price Efficacy Dose messenger RNA. Moderna expects Submitted to have 20M doses for the U.S. in for review (Per dose) December and 100M gllbally in Q1. $19.50* 95% 2 Trial 21 Days Apart AstraZeneca/Oxford paused Results Approvals $25-$37 95% 2 65k 2 2-8°c 70% AstraZeneva struck deals for 3 billion 28 Days Apart doses even before any late-stage Trial Trial study results. That’s more than twice start resumed $25-$37 70% 2 as many as any other candidate. 28Days Apart Initial clinical results were mixed. Early Remark: * $19.50 per dose for first 100 million doses approvals Sinovac Biotech Source: New York Times, BioSpace, Bloomberg 26k 2 2-8°c 50% Note: Information as of February 6, 2021 Sinovac’s vaccine triggers an immune responses using the Trial Results Covid-19 virus itself, after it has been start chemically inactivated.
*China took the unusual step of allowing vaccine distribution before conducting large-scale clinical trials.
4 Economic Outlook Report 2021 | Special Edition
Global Economy Overview 2021
5 Economic Outlook Report 2021 | Special Edition
Global economy remains prone to setbacks due to recent COVID-19 resurgence. Although, the IMF revised up 2020 growth, the recovery in 2021 is likely to be gradual, supported by vaccine progress and stimulus packages. With the exception of China, most key economies’ growth in 2021 should remain well below their pre-pandemic levels.
5.2 E in 8.2 i 1 1.9 -8.3 0 2020F 2021F 2020F 2021F
2.3